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Changing epidemiology of HIV anonymous
testing in Switzerland for 1996–2006
Leonie R. Prasad, Adrian Spoerri, Martin D. Gebhardt, Matthias Egger, Nicola Low, Marcel Zwahlen
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Questions under study: To assess whether the
prevalence of HIV positive tests in clients at five
anonymous testing sites in Switzerland had in-
creased since the end of the 1990s, and ascertain
whether there had been any concurrent change in
the proportions of associated risk factors.
Methods: Baseline characteristics were ana-
lysed, by groups of years, over the eleven consecu-
tive years of data collected from the testing sites.
Numbers of HIV positive tests were presented as
prevalence/1000 tests performed within each cat-
egory. Multivariable analyses, stratified by African
nationality and risk group of heterosexuals or
men who have sex with men (MSM), were done
controlling simultaneously for a series of vari-
ables. Odds ratios (ORs) were reported together
with their 95% confidence intervals (CI). P values
were calculated from likelihood ratio tests.
Results: There was an increase in the preva-
lence of positive tests in African heterosexuals be-
tween 1996–1999 and 2004–2006, rising from
54.2 to 86.4/1000 and from 5.6 to 25.2/1000 in
females and males respectively. The proportion of
MSM who knew that one or more of their sexual
partners was infected with HIV increased from
2% to 17% and the proportion who reported
having more than five sexual partners in the pre-
ceding two years increased from 44% to 51%.
Conclusions: Surveillance data from anony-
mous testing sites continue to provide useful in-
formation on the changing epidemiology of HIV
and thus inform public health strategies against
HIV.
Key words: HIV; Switzerland; anonymous testing
sites
Summary
Globally HIV infection has reached pan-
demic proportions, accounting for over 65 mil-
lion infections and 25 million deaths to date [1].
The highest prevalence percent in the age group
15–49 years is in sub-Saharan Africa (5.0%) [2].
In western Europe in 2006, the rate of re-
ported newly diagnosed HIV cases was 82.5 per
million population; the predominant mode of
transmission was heterosexual [3]. Among the
20 European Union countries which have consis-
tently reported HIV data since 1999, the rate of
newly diagnosed infections reported nearly dou-
bled from 28.8/million in 1999 to 57.5/million in
2006. This increase was mainly accounted for by
heterosexuals and MSM; cases in injection drug
users (IDUs) had declined overall [3].
Switzerland is a country with an HIV epi-
demic that is concentrated in high-risk groups.
The rate of reported newly diagnosed infections
in 2006 was 104/million population [3].There is a
low prevalence of HIV in the general population
(around 0.3%, 2006 estimate) [4]. Surveillance for
HIV has been in place since 1985, and HIV has
been statutorily notifiable since 1 December 1987
[5]. As part of this surveillance some 30 different
sites across Switzerland have provided the Swiss
Federal Office of Public Health with epidemio-
logical information on persons presenting for
anonymous HIV counselling and tests.
The proportion of recent infections (occur-
ring within the previous six months) in MSM in
Switzerland had increased from 19% to 38% be-
tween 2001 and 2006 [6, 7]. This substantial in-
crease was unexpected, since the annual numbers
from all surveillance sources had shown a declin-
ing trend during most of the 1990s.
The present analysis was undertaken to as-
sess, firstly, whether there had been an increase in
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the prevalence of HIV positive tests since the end
of the 1990s in clients at a sample of the anony-
mous HIV testing sites, and, secondly, to ascertain
whether there had been any concurrent change in
the proportions of reported HIV-associated risk
factors.
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Methods
Questionnaires at the anonymous HIV testing sites
are available in German, French or Italian, and are com-
pleted anonymously by the clients themselves or in con-
junction with their pre-test counsellor. The questions
cover information on demographics (e.g., sex, national-
ity), reasons for requesting an HIV test, results of any
previous HIV test and history of injection drug use.
Other questions relate to a relevant past sexual or medical
history. Questions on sexual history include: types of sex-
ual relationships e.g., MSM or heterosexual, knowledge
of a sexual partner’s positive HIV status, number of sexual
partners in the previous two years, condom use in the
preceding two years with occasional sexual partners and
history of gonorrhoea or syphilis. Questions relating to
the past medical history include whether and in what
country they have at any time received a transfusion of
blood or blood products. Completed questionnaires are
forwarded to the Swiss Federal Office of Public Health
where they are transferred to an electronic database for
analysis. Missing information cannot be filled in because
of client anonymity, and it is impossible to know whether
any of the questionnaires refer to the same person.
Statistical analyses
Data included in this analysis were from the five
anonymous testing sites based in outpatient centres of the
university hospitals in Basel, Bern, Geneva, Lausanne and
Zurich, which had provided annual data over the eleven
consecutive years under study (1996–2006). We grouped
the time period into three categories: 1996–1999, 2000–
2003 and 2004–2006. The prevalence of HIV positivity
per 1000 was calculated by dividing the number of posi-
tive HIV tests by the total number tested within each cat-
egory and multiplying by 1000.We did this for a series of
categorical variables: testing sites, gender, nationality
groups, age groups and risk groups (heterosexual males,
heterosexual females, MSM and IDUs).
We assessed associations of client characteristics with
HIV positivity using multivariable logistic regression
analysis with a positive HIV test as the outcome.We con-
ducted separate analyses for male and female heterosexu-
als and for MSM. The number of tested clients reporting
IDU as a risk factor was too small (1063/141 076; 0.75%)
to allow separate analysis. We simultaneously monitored
for age, nationality, number of occasional sexual partners
in the last two years, condom use with occasional sexual
partners, knowledge of sexual contact with an HIV-in-
fected person and a history of gonorrhoea or syphilis. Na-
tionality was grouped into Swiss, other European except
Swiss and then by continent. African nationalities mainly
consisted of countries classified as sub-Saharan Africa. Ef-
fect modification was explored by including interaction
terms in the logistic regression model. For the multivari-
able analyses we performed a complete case analysis. In a
sensitivity analysis we redid the analysis by including in-
dicators for the missing categories of the variables in-
cluded.
We report adjusted odds ratios and their 95% confi-
dence intervals (CI) from the logistic regression analyses.
P values were calculated from likelihood ratio tests.
All analyses were performed with STATA 9.2 (Stata-
Corp, College Station, Texas).
Ethics and financial support
Data collection at the anonymous HIV test sites is
anonymous and all persons who visit these anonymous
HIV test sites are free to refuse to answer selected or all
questions. Due to the fact that the persons remain anony-
mous no written informed consent can be obtained. The
work on this manuscript was supported financially by a
contract of the Swiss Federal Office of Public Health.
The data collection at the five anonymous HIV test sites
over these eleven years was financially supported by spe-
cific contracts of the Swiss Federal Office of Public Health.
Results
Anonymous tests and baseline characteristics
of attendees
Table 1 shows that the sites providing the
most questionnaires, over the whole 11-year pe-
riod, were Geneva (38971; 28%) and Zurich
(38558; 27%).The total number of clients attend-
ing all sites together varied by year with the low-
est (10426) attending in 1999 and the highest
(15138) in 2003. The majority of tests taken were
in those who described themselves as heterosexual
(130697, 93%). Swiss nationals accounted for
77% (109092) of the tests, 14% (19886) were of
another European nationality, 3% (3902) were
from the Americas, 2% (3412) were African and
1% (1141) were Asian. 42% of the persons taking
an anonymous HIV test were 25–34 years of age.
Risk factors of individuals attending
anonymous test sites
We found evidence of interaction between
heterosexuals of African nationality and the vari-
ables of age and knowledge of an HIV infected
sexual partner. We therefore present a stratified
analysis for this group as well. However, Africans
made up only 0.9% (88/10103) of MSM, and
hence we did not analyse them separately for this
risk group. Including missing variables in the mul-
tivariable analyses did not change the interpreta-
tion of our results. We therefore presented the
results from the complete case analyses, but re-
ported the number of questionnaires with missing
information on certain items in the tables for dis-
cussion purposes.
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With respect to risk factors, the proportion of
MSM reporting that they had had more than five
sexual partners in the last two years rose from
44% in 1996–1999 to 51% in 2004–2006 (fig. 1).
Also in MSM, sexual contact with a known HIV-
infected partner rose from around 2% to 17%
over the same time period. Reporting a history of
ever having had syphilis or gonorrhoea remained
fairly stable over the eleven years in all three risk
groups studied. However, the proportion of both
of these sexually transmitted infections (STIs) re-
ported in MSM was higher than in heterosexuals
over the same time period (fig. 1).
Risk factors for an HIV-positive test
(stratified multivariable analyses)
Non-African heterosexuals & MSM
In MSM, those aged 35–44 years had 1.7
times higher odds (95% CI: 1.2–2.5) of testing
HIV positive than those aged 25–34 years (table
2). Female heterosexuals aged 45 years and over
had 2.8 times higher odds (95% CI: 1.4–5.8) of
testing HIV positive compared with those aged
25–34 years. They also had higher odds of testing
positive in 1996–1999 (OR 3.1; 95% CI 1.5–6.6)
and 2004–2006 (OR 2.3; 95% CI 1.1–4.6) than in
2000–2003. Compared with Swiss nationals,
Asian nationals had the highest odds of testing
HIV positive for male heterosexuals and MSM,
with an OR of 6.1 (95% CI: 2.5–15.2) and 6.0
(95% CI: 2.3–15.7) respectively. For female het-
erosexuals, the highest odds of HIV positivity
were in subjects from the Americas (OR 5.9, 95%
CI: 3.1–11.3). When including centre in these
analyses, no statistically significant heterogeneity
by centre was found.
With respect to risk factors and other medical
history information for MSM, those with a maxi-
mum of one new partner in the last two years had
3.2 times higher odds (95% CI: 1.7–6.3) of HIV
positivity compared with those who reported be-
SWISS MED WKLY 20 09 ; 139 ( 17–18 ) : 256–263 · www.smw.ch
Characteristic Number tested (prevalence HIV positive per 1000) Total number Total number HIV
tested positive
(prevalence per 1000)
1996–1999 2000– 2003 2004–2006
Total 45 971 53 584 41521 141076 516 (3.7)
Center
Basel 7181 (4.2) 6152 (2.3) 3533 (4.2) 16866 59 (3.5)
Bern 4830 (3.1) 6084 (2.6) 6274 (2.9) 17188 49 (2.9)
Geneva 11544 (2.9) 15624 (4.6) 11803 (4.2) 38971 156 (4.0)
Lausanne 10379 (3.7) 10857 (3.0) 8257 (4.6) 29493 109 (3.7)
Zurich 12037 (5.2) 14867 (2.6) 11654 (3.5) 38558 143 (3.7)
Nationality
Swiss 36048 (3.1) 41155 (1.7) 31889 (1.9) 109092 243 (2.2)
Europe without Switzerland 6580 (4.1) 7395 (3.2) 5911 (3.2) 19886 70 (3.5)
Africa 851 (22.3) 1459 (36.3) 1102 (50.8) 3412 128 (37.5)
Americas 1156 (9.5) 1557 (8.3) 1189 (13.5) 3902 40 (10.3)
Asia 352 (11.4) 467 (10.7) 322 (9.3) 1141 12 (10.5)
Missing 984 (6.1) 1551 (5.8) 1108 (7.2) 3643 23 (6.3)
Age group
16 – 24 14565 (1.6) 16399 (1.7) 11809 (1.3) 42773 67 (1.6)
25 – 34 19710 (4.4) 22160 (3.2) 17036 (4.0) 58906 227 (3.9)
35 – 44 7231 (6.4) 9362 (5.9) 7737 (6.9) 24330 154 (6.3)
>=45 4012 (4.7) 4989 (3.4) 4249 (4.9) 13250 57 (4.3)
Missing 453 (8.8) 674 (3.0) 690 (7.2) 1817 11 (6.0)
Risk group
Male heterosexual 23669 (2.4) 27712 (2.4) 21596 (2.0) 72977 167 (2.3)
Female heterosexual 18407 (3.0) 21741 (2.1) 16785 (3.9) 56933 169 (2.9)
MSM 3336 (16.8) 3807 (14.2) 2960 (16.9) 10103 161 (15.9)
IDU 559 (19.7) 324 (24.7) 180 (11.1) 1063 21 (19.8)
Table 1
Baseline characteris-
tics of those present-
ing for HIV tests at
the five anonymous
testing sites based in
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the university hospi-
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Changing epidemiology of HIV anonymous testing in Switzerland for 1996–2006
Characteristic Heterosexual males* Heterosexual females* MSM
No. tested Prevalence Adjusted No tested Prevalence Adjusted No Prevalence Adjusted Odds
HIV positive Odds Ratio HIV positive Odds Ratio tested HIV positive Ratio (95% CI)†
per 1000 (95% CI)† per 1000 (95% CI)† per 1000
Total 70895 55700 10103
Agegroup
16–24 17235 1.3 0.90 (0.54–1.49) 22806 0.75 0.62 (0.32–1.17) 1698 6.5 0.47 (0.23–0.96)
25 – 34 31029 1.8 Ref 21 602 1.5 Ref 4226 14.9 Ref
35 – 44 13657 2.4 1.34 (0.84–2.15) 7025 2.7 1.40 (0.71–2.75) 2652 24.5 1.72 (1.17–2.54)
>=45 8227 1.6 0.86 (0.44–1.69) 3446 4.9 2.85 (1.40–5.80) 1397 13.6 1.03 (0.59–1.81)
missing 747 1.3 – 821 1.2 – 130 23.1 –
P = 0.4409 P = 0.0034 P = 0.0004
Year
1996–1999 23136 2.3 1.35 (0.86–2.12) 18112 2.2 3.15 (1.51–6.57) 3336 16.8 1.15 (0.73–1.79)
2000–2003 26799 1.7 Ref 21231 0.75 Ref 3807 14.2 Ref
2004–2006 20960 1.2 0.78 (0.46–1.31) 16357 1.8 2.28 (1.12–4.62) 2960 17.2 1.08 (0.71–1.64)
P = 0.0962 P = 0.0039 P = 0.8318
Nationality
Swiss 55880 1.6 Ref 44991 1.2 Ref 7436 11.8 Ref
Europe 10948 1.7 0.82 (0.46–1.44) 7058 1.3 1.01 (0.45–2.25) 1686 21.4 1.71 (1.12–2.60)
without CH
Africa excluded excluded excluded excluded excluded excluded 88 45.5 3.17 (0.95–10.57)
Americas 1572 3.2 1.14 (0.36–3.63) 1858 8.1 5.89 (3.07–11.31) 447 44.7 3.25 (1.83–5.74)
Asia 574 8.7 6.13 (2.47–15.24) 468 2.1 1.84 (0.25–13.66) 93 53.8 6.03 (2.32–15.69)
missing 1921 2.6 – 1325 6.8 – 353 22.7 –
P = 0.0160 P = 0.0001 P <0.001
Number of partners in the last two years
0–1 9894 1.8 1.16 (0.64–2.09) 11470 3.0 1.66 (0.93–2.98) 797 22.6 3.25 (1.67–6.33)
2–5 46746 1.6 Ref 38273 1.0 Ref 4283 10.3 Ref
>5 12631 2.3 1.33 (0.84–2.12) 4713 1.5 1.33 (0.55–3.21) 4730 19.2 1.45 (0.98–2.16)
missing 1624 1.8 – 1244 4.8 – 293 27.3 –
P = 0.4655 P = 0.2213 P = 0.0028
Knowledge of HIV-infected sexual partner
Yes 1274 9.4 5.55 (2.85–10.82) 1040 17.3 8.02 (4.14–15.54) 1180 35.6 2.40 (1.57–3.68)
No 69621 1.6 Ref 54660 1.2 Ref 8923 13.3 Ref
P <0.001 P <0.001 P = 0.0001
Condom use with occasional partners
Always 28616 1.7 Ref 16866 1.4 Ref 5486 12.6 Ref
Sometimes 22831 2.1 1.19 (0.77–1.82) 17454 1.3 0.97 (0.53–1.78) 2703 24.8 2.07 (1.44–2.99)
Never 4143 1.9 1.05 (0.46–2.40) 4088 1.5 0.63 (0.23–1.73) 588 15.3 1.14 (0.52–2.48)
No occasional 13092 1.2 0.91 (0.48–1.73) 14998 1.5 0.97 (0.46–2.02) 974 8.2 0.40 (0.16–1.00)
partner in the
last two years
Missing 2213 2.3 – 2294 4.8 – 352 22.7 –
P = 0.8246 P = 0.8120 P = 0.0001
History of gonorrhoea
Yes 1577 5.1 1.79 (0.70–4.54) 278 7.2 1.77 (0.24–13.26) 784 37.0 2.31 (1.45–3.67)
No 68056 1.7 Ref 54214 1.4 Ref 9060 13.6 Ref
Missing 1262 4.0 – 1208 5.8 – 259 34.7 –
P = 0.2576 P = 0.6072 P = 0.0009
History of syphilis
Yes 184 10.9 6.53 (1.53–27.89) 62 0.0 – 233 38.6 1.49 (0.65–3.38)
No 69255 1.7 Ref 54 445 1.4 – 9545 15.1 Ref
Missing 1456 5.5 – 1193 5.9 – 325 24.6 –
P = 0.0460 P = 0.3659
All variables listed in the table were entered in the logistic regression models by incorporating appropriately constructed indicator variables.
* Excludes African nationals; † Missings excluded from the multivariable analysis; P values from likelihood ratio tests
Table 2
Stratified multivariable logistic regression analyses for non-African heterosexual and men who have sex with men clients at the five anonymous
testing sites based in outpatient centres of the university hospitals in Basel, Bern, Geneva, Lausanne and Zurich (Switzerland): 1996–2006.
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Characteristic Heterosexual males Heterosexual females
No. tested Prevalence Adjusted No tested Prevalence Adjusted
HIV positive Odds Ratio HIV positive Odds Ratio
per 1000 (95% CI)* per 1000 (95% CI)†
n = 1436 n = 1015
Total 2082 1233
Age group
16–24 439 9.1 0.53 (0.15–1.89) 391 28.1 0.18 (0.07–0.43)
25–34 983 15.3 Ref 558 93.2 Ref
35–44 496 32.3 1.98 (0.90–4.34) 217 55.3 0.42 (0.18–0.95)
>=45 131 38.2 1.04 (0.22–4.84) 40 125 0.89 (0.25–3.19)
Missing 33 0.0 – 27 111.1 –
P = 0.1362 P <0.001
Year
1996–1999 533 5.6 0.10 (0.01–0.77) 295 54.2 0.97 (0.42–2.23)
2000–2003 913 23.0 Ref 510 58.8 Ref
2004–2006 636 25.2 1.02 (0.48–2.14) 428 86.4 1.58 (0.85–2.92)
P = 0.0067 P = 0.2575
Number of partners in the last two years
0–1 388 25.8 1.24 (0.49–3.11) 426 70.4 1.04 (0.56–1.94 )
2-5 1318 18.2 Ref 650 56.9 Ref
>5 240 0.0 – 79 63.3 1.08 (0.35–3.35)
Missing 136 44.1 – 78 141.0 –
P = 0.6542 P = 0.9836
Knowledge of HIV-infected sexual partner
Yes 71 98.6 7.82 (2.92–20.90) 32 66.6 2.73 (0.75–9.96)
No 2011 16.4 Ref 1201 93.7 Ref
P = 0.0005 P = 0.1672
Condom use with occasional partners
Always 766 13.0 Ref 247 44.5 Ref
Sometimes 520 23.1 1.65 (0.66–4.13) 255 70.6 1.84 (0.78–4.38)
Never 128 7.8 excluded† 117 42.7 0.90 (0.25–3.18)
Had no occasional 541 24.0 1.07 (0.42–2.72) 498 64.3 1.62 (0.68–3.90)
partner in the
last two years
Missing 127 31.5 – 116 146.5 –
P = 0.5293 P = 0.3578
History of gonorrhoea
Yes 100 50.0 1.53 (0.41–5.74) 8 125 2.05 (0.23–18.63)
No 1893 17.4 Ref 1157 60.5 Ref
Missing 89 22.5 – 68 176.5 –
P = 0.5457 P = 0.5511
History of syphilis
Yes 32 62.5 6.85 (1.35–34.87) 12 83.3 2.54 (0.30–21.56)
No 1962 18.3 Ref 1158 60.4 Ref
Missing 88 22.7 – 63 190.5 –
P = 0.0528 P = 0.4442
All variables listed in the table were entered in the logistic regression models by incorporating appropriately constructed indicator
variables. * Missings excluded from the multivariable analysis; P values from likelihood ratio tests. † Only 1 positive HIV result in this
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tween two and five new partners in the last two
years. Knowledge of an HIV-infected sexual part-
ner was also associated with testing HIV positive,
with an odds ratio of 5.5 (95% CI: 2.8–10.8) in
male heterosexuals, 8.0 (95% CI: 4.1–15.5) in fe-
male heterosexuals and 2.4 (95% CI: 1.6–3.7) in
MSM. Compared with those who always used
condoms with occasional sexual partners, MSM
with “sometimes” use of condoms had higher
odds of testing HIV positive (OR 2.1, 95% CI:
1.4–2.99). Male heterosexuals who reported a his-
tory of syphilis had higher odds of testing HIV
positive (OR 6.5, 95% CI: 1.5–27.9) than those
who did not report a history of syphilis. For
MSM, a history of gonorrhoea was significantly
associated with testing positive for HIV (OR 2.3,
95% CI: 1.4–3.7). In 2004–2006 the proportion of
those testing positive who had had a history of
gonorrhoea almost doubled compared with 2000–
2003, rising to 25% (13/51) from 13% (7/54).
African heterosexuals
There was an increase in the proportion of
HIV positive tests for male heterosexuals, rising
from 5.6 to 25.2/1000 between 1996–1999 and
2004–2006. The odds of testing positive were
much lower in 1996–1999 (OR 0.01, 95% CI:
0.01–0.8) than 2004-2006 (OR 1.01, 95% CI:
0.5–2.1) (table 3). Knowledge of an HIV-infected
sexual partner was also associated with higher
odds of testing HIV positive (OR 7.8, 95% CI:
2.9–20.9), as was a history of having been infected
with syphilis (OR 6.8, 95% CI: 1.3–34.9).
For female heterosexuals the proportion of
HIV positive tests increased from 54.2 to
86.4/1000 between 1996–1999 and 2004–2006.
Compared to those aged 25–34, all other age-
groups had lower odds of testing positive for HIV.
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Discussion
Our findings showed that between 1996 and
2006 there was an increase in the prevalence of
HIV positive tests for male and female African
heterosexuals at the five anonymous testing sites
that we studied. A published study on the HIV
epidemic in western Europe between 1997 and
2002, based on twelve countries, showed that the
number of newly diagnosed infections increased
greatly (122%) in heterosexuals, largely as a result
of infections in persons from countries with gen-
eralised epidemics such as sub-Saharan Africa [8].
In MSM,we found higher odds of testing pos-
itive in those aged 35–44 years (OR 1.7) compared
to those aged 25–34. These findings are largely
within the age-group, of 15–49 years, reported to
have thehighestHIVprevalence inwesternEurope
[2]. For heterosexual females not of African na-
tionality we found higher odds of testing positive
(OR 2.8) in the older age group of >=45 years than
those aged 25–34. Further analysis (not shown) re-
vealed that the majority of this group who tested
positive were Swiss, had a knownHIV positive sex-
ual partner, never used condoms with their regular
partner and knew that theywere at risk.ForAfrican
females, all age-groups had lower odds (ORs <1) of
testing positive than the reference group (25–34).
This is supported by global reports of the highest
prevalence percent of HIV occurring in younger
African women, particularly from sub-Saharan
countries [2].
On the basis of the data collected it is not pos-
sible to explain the difference in odds of testing
HIV positive by nationality group for heterosexu-
als who were not African and MSM. However, it
could be speculated that persons from Asia and
the Americas included a large number of commer-
cial sex workers, information on whom was not
specifically requested in the questionnaire.
Swiss national surveillance data have shown
that MSM had the highest proportion of recently
acquired infections (within the preceding six
months), rising from 19% in 2001 to 38% in 2006
[6, 7, 9]. Unfortunately we had no data to assess
the proportion of infections that had been ac-
quired in the preceding six months. We did have
data, however, related to risk factors for acquisi-
tion of HIV. Our analysis showed that almost half
(47%; 4730/10103) of MSM had had more than
five sexual partners in the preceding two years and
that around 12% (1180/10103) reported having
had sexual contact with an HIV-infected partner.
Knowledge of an HIV positive sexual partner in-
creased substantially in MSM over the eleven years
covered in this analysis, rising from 2% to 17%,
and we also found higher odds of testing positive
if they knew their sexual partner was infected (OR
2.4). The increase in proportions of these two risk
factors could have contributed to the recent in-
crease in newly diagnosed HIV infections in
MSM. A “Gay Survey” done in Switzerland in
2004 showed that MSM had increased their risk-
taking behaviour not only in having a larger num-
ber of sexual partners in the preceding twelve
months but also undertaking anal penetration with
regular or occasional partners and fewer using
condoms with occasional partners, particularly in
men aged below 20 years [10].The CH.A.T survey
(Swiss AIDS Transmission Survey) also identified
that preventive measures were not always being
used, particularly among MSM, because of an ap-
parent lack of concern about HIV [11, 12].We also
found significantly higher odds of testing positive
in non-African heterosexuals and male heterosexu-
als of African nationality, if they knew their sexual
partner was infected, which in addition to the same
finding in MSM implies a substantial risk of trans-
mission in discordant sexual partnerships.
Interestingly, for the question relating to
number of sexual partners in the preceding two
years, the prevalence of positive HIV tests was
highest in the “missings” category for all risk
groups apart from non-African male heterosexu-
als. This suggests that this category could include
persons who had had at least five sexual partners
but who for some reason did not want to tick the
appropriate box in the questionnaire. We also
found that, for MSM, the odds of testing positive
were higher in the category of 0–1 partners (OR
3.2) than >5 partners. This is difficult to interpret,
but it may represent a group of people already at a
stage of illness that affected their lifestyle, which
included them having fewer sexual partners.Alter-
natively it could represent those whose stable
partners have multiple other sexual partners, thus
putting them at increased risk of acquiring HIV
from their stable partner.
262
Our analysis showed that a history of gonor-
rhoea increased the odds of testing HIV positive
by a factor of around two in MSM. National sur-
veillance data for STIs in Switzerland, based on
data from six dermatology policlinics serving the
major cities in Switzerland, showed that between
1997 and 2003 MSM accounted for most of the
cases of gonorrhoea (43%) and an increasing pro-
portion of syphilis (9%, 2/24 in 1997 to 48%,
24/50 in 2003) [13]. Sexually transmitted infec-
tions, either current or past, enhance the risk of
acquiring and transmitting HIV [14, 15]. An in-
crease in the prevalence of STIs combined with
an increase in risky sexual behaviour in a popula-
tion that already has a high prevalence of HIV has
the potential to increase HIV transmission in this
risk group.
We also found that the odds of testing posi-
tive for HIV in the presence of a history of
syphilis were around seven times higher for het-
erosexual males of both African and non-African
nationalities. This finding is consistent with the
findings for a history of gonorrhoea.
The results presented are based on data col-
lected over eleven consecutive years at the five
largest anonymous HIV testing centres in Switzer-
land. These centres have been operational since
1985 and have over two decades of experience in
collecting data for analysis via questionnaires. The
questionnaire itself has only been slightly revised,
once over the years covered by this analysis, and
did not undergo significant changes in classifica-
tion of those variables collected in the earlier ver-
sion. Hence the variables described were directly
comparable over the analysis period.
There are also clear limitations to this type of
data and their analysis. The information is self-
reported, so it may have been subject to over-
reporting of socially acceptable behaviours and
under-reporting of those that were socially unac-
ceptable. In addition, persons with high risk be-
haviour may prefer to be tested elsewhere, such as
specialist clinics.This may have resulted in under-
estimation of the influence of risk factors and
behaviours associated with testing HIV positive.
Another limitation, mentioned earlier, was that
results could be distorted by the same persons
repeatedly attending an anonymous testing site,
which could not be accounted for in the analysis
as the questionnaires were anonymous. Data for
reported HIV diagnoses do not represent HIV
incidence, but include many persons found to be
HIV positive who were infected at some time in
the past. The prevalence of those testing positive
also depends on the uptake of HIV testing and
the prevalence of HIV in those being tested,
which may have varied over time and between
persons with different combinations of risk fac-
tors. For example, studies have reported that since
the advent of highly active antiretroviral therapy,
which was introduced in Switzerland in 1996, an
increased number of MSM have been tested [16].
In the data included here, the mean annual num-
ber of tests performed in MSM increased steadily
from 834 in 1996–1999 to 987 in 2004–2006. Part
of the “HIV in Europe 2007” initiative is to in-
crease the number of persons who are tested so
that antiretroviral therapy (ART) can be started
earlier in the course of disease (www.hiveurope
2007.eu). Anonymous HIV testing may con-
tribute to earlier diagnosis and thus to treatment
of HIV earlier in the course of HIV disease. Sev-
eral recently published studies have shown signifi-
cantly lower mortality rates in those initiating
ART when CD4 cell counts are >= 200 cells/μL
than in those who initiate therapy later in the
course of the disease, when CD4 counts are <50–
100 cells/μL [17, 18].
The data analysed came from university hos-
pital sites serving the largest urban centres in
Switzerland and were unlikely to be representa-
tive of the whole of Switzerland. In addition, we
were unable to perform any meaningful analysis
of persons reporting IDU, who are also an impor-
tant risk group for HIV infection. A cross-sec-
tional telephone survey in Switzerland showed
that clientele of anonymous HIV test centres
tended to be younger, single and with a higher
proportion reporting a new steady partner in the
preceding year compared with those taking tests
in the general population [19, 20]. Our data were
in accordance with this in that the majority being
tested were under 35 years of age and most had
had at least one new partner in the previous two
years. Because each test costs around $30, this
may have caused further biases in selecting only
those persons able to afford the test, who may also
have differed in other socio-demographic and
risk-taking behaviours from the wider MSM and
heterosexual populations.
SWISS MED WKLY 20 09 ; 139 ( 17–18 ) : 256–263 · www.smw.ch
Conclusions
The finding of a high and increasing preva-
lence of positive tests in African heterosexuals,
who were chiefly from countries of sub-Saharan
Africa, was in accordance with western European
findings [8]. Even if the majority of these infec-
tions occurred in their countries of origin, there is
still the risk of acquisition and transmission of
HIV once in Switzerland. Hence culturally sensi-
tive public health interventions at all levels (pri-
mary, secondary and tertiary) are required in this
risk group [4, 9, 21].
On the basis of an analysis of our data, we can
put forward a number of hypotheses relating to
risk factors associated with acquisition of HIV in-
fection, which could also explain why the figures
for recently acquired HIV infections have under-
gone a disturbing increase in MSM in Switzer-
land in recent years. Firstly, more MSM were en-
gaging in sexual relationships with partners who
were known to be HIV positive. Secondly, the
proportion of those testing HIV positive who re-
ported a history of gonorrhoea increased, which
would have presented a higher risk of transmit-
ting HIV. Finally, there was an increase in the
proportion of MSM who reported that they had
had more than five sexual partners in the preced-
ing two years. Given that the probability of meet-
ing an infected partner is many times higher in
the gay than in the heterosexual population, hav-
ing more sexual partners presents a very real risk
of acquiring HIV among MSM in discordant re-
lationships, especially if there is a reduction in the
use of preventive methods as has been reported in
the Swiss Gay Survey [10, 20].
This study shows that anonymous HIV test
site data, together with surveillance data from
other sources, continue to provide useful infor-
mation for monitoring of HIV and realignment
of HIV prevention activities.
We thank the counsellors at the anonymous HIV
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sons attending for an anonymous HIV test.Without their
diligent efforts this work would not have been possible.
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